Anticancer Drug Classes: A Simple Guide

Traditional chemotherapy drugs work by targeting rapidly dividing cells.Cancer cells divide more rapidly than most normal cells, making them more susceptible to these drugs.The first major class is alkylating agents, like cyclophosphamide, which work by damaging the DNA structure of cancer cells.Antimetabolites like 5-fluorouracil work by interfering with DNA and RNA synthesis, preventing cell replication.Plant alkaloids like vincristine work by disrupting cell division, preventing cancer cells from completing mitosis.While effective against cancer cells, these drugs can also affect healthy rapidly dividing cells, leading to common side effects.These side effects include hair loss, decreased blood cell counts, and nausea, requiring careful monitoring during treatment.Targeted therapies represent a more precise approach to cancer treatment, focusing on specific molecules involved in cancer growth and spread.Unlike traditional chemotherapy that affects all rapidly dividing cells, targeted therapies are designed to attack specific features of cancer cells.Tyrosine kinase inhibitors, like imatinib, work by blocking specific proteins that signal cancer cells to grow.Monoclonal antibodies, such as trastuzumab, are designed to target specific receptors found on cancer cells.PARP inhibitors work differently, interfering with the DNA repair process that cancer cells rely on to survive.Let's compare targeted therapy with traditional chemotherapy to understand their key differences.The specific nature of targeted therapies means they generally have fewer side effects compared to traditional chemotherapy, as they primarily affect cancer cells rather than all rapidly dividing cells.These targeted approaches have significantly improved cancer treatment outcomes while reducing side effects.Immunotherapy drugs work by enhancing the body's natural immune response against cancer.Let's start with checkpoint inhibitors like pembrolizumab. Normally, cancer cells can activate checkpoint proteins that prevent T-cells from attacking.Checkpoint inhibitors block these proteins, allowing T-cells to recognize and attack cancer cells.CAR T-cell therapy is a more advanced form of immunotherapy where we modify a patient's own T-cells.The process involves collecting T-cells, modifying them in the lab to target cancer, multiplying them, and returning them to the patient.Cancer vaccines represent another approach to immunotherapy, training the immune system to recognize and attack cancer cells.These vaccines contain specific components that help stimulate an immune response against cancer.While effective, immunotherapy can cause unique immune-related side effects that need careful monitoring.Immunotherapy has revolutionized cancer treatment, offering new hope through personalized immune approaches and combination therapies.Thank you for learning about cancer immunotherapy with Spark.E!